These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30980642)

  • 1. Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors.
    Ranjbar Kermani F; Mousavi Hosseini K; Amini Kafi-Abad S; Mansournia MA; Sharifi Z; Maghsudlu M
    Arch Iran Med; 2019 Feb; 22(2):76-79. PubMed ID: 30980642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of hepatitis C virus in viremic blood donors in Iran: Need to reinforce post-donation follow up.
    Kermani FR; Hosseini KM; Kafi-Abad SA; Maghsudlu M; Sharifi Z; Mansournia MA
    Transfus Apher Sci; 2022 Jun; 61(3):103353. PubMed ID: 35123894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.
    Bernardin F; Tobler L; Walsh I; Williams JD; Busch M; Delwart E
    Hepatology; 2008 May; 47(5):1446-52. PubMed ID: 18220272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of viremia and the heterogeneity of hepatitis C virus genotypes among blood donors, hemophiliacs and patients with chronic liver disease.
    Kuperan P; Aw TC; Ishiko H; Hashimoto O; Takeda N
    Pathology; 1996 Nov; 28(4):348-51. PubMed ID: 9007955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Vinson S; Mousa M; Gitnick G
    Nephron; 1998 Dec; 80(4):428-33. PubMed ID: 9832642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hepatitis C infection among blood donors in northeastern Thailand.
    Songsivilai S; Jinathongthai S; Wongsena W; Tiangpitayakorn C; Dharakul T
    Am J Trop Med Hyg; 1997 Jul; 57(1):66-9. PubMed ID: 9242321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of hepatitis C viremia in renal allograft recipients.
    Mahmoud IM; Sobh MA; Amer GM; El-Chenawy FA; Gazareen SH; El-Sherif A; El-Sawy E; Ghoneim MA
    Am J Nephrol; 1999; 19(5):576-85. PubMed ID: 10575187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-8 is associated with non-viremic state and IFN-γ with biochemical activity in HCV-seropositive blood donors.
    Zarife MA; Reis EA; Meira GC; Carmo TM; Lopes GB; Malafaia EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
    Intervirology; 2011 Feb; 54(2):87-96. PubMed ID: 20829604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients.
    Bal T; Onlen Y; Babayigit C; Yumer Y; Sahin SI
    Afr Health Sci; 2019 Jun; 19(2):1988-1992. PubMed ID: 31656481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
    Bastani MN; Bokharaei-Salim F; Keyvani H; Esghaei M; Monavari SH; Ebrahimi M; Garshasebi S; Fakhim S
    Arch Virol; 2016 Jul; 161(7):1899-906. PubMed ID: 27132015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.